LP-184 May Expand Options for Pancreatic Cancers With DDR Defects
Trial-In-Progress Looks to Prophylactic Tocilizumab to Reduce CRS in Patients with Multiple Myeloma
Opioid-free discharge not linked with greater readmission following kidney cancer surgery
Telix submits BLA for kidney cancer imaging agent
Pharmacy firm eyes 2024 rollout of 1st targeted PET imaging agent for kidney cancer
ctDNA Could Aid in Treatment Escalation and De-escalation Decisions in Kidney Cancer
Cameron Mathison is 'cancer-free'
Ottawa triathlete wins access to U.S. clinical trial for advanced pancreatic cancer
Onslow family raises $75,000 for fight against pancreatic cancer
W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute